Calpain and Cardiometabolic Diseases
International Journal of Molecular Sciences · 26.11.2023 · 24 (23) · 16782
DOI: 10.3390/ijms242316782 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 26.11.2023. Verfasst von Takuro Miyazaki. Beteiligte Einrichtung: Department of Biochemistry, Showa University School of Medicine, Tokyo 142-8555, Japan. Hauptthemen laut MEDLINE: Calpain, Atherosclerosis. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 118 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Japan Society for the Promotion of Science KAKENHI.
Abstract (Originalsprache)
Calpain is defined as a member of the superfamily of cysteine proteases possessing the CysPC motif within the gene. Calpain-1 and -2, which are categorized as conventional isozymes, execute limited proteolysis in a calcium-dependent fashion. Accordingly, the calpain system participates in physiological and pathological phenomena, including cell migration, apoptosis, and synaptic plasticity. Recent investigations have unveiled the contributions of both conventional and unconventional calpains to the pathogenesis of cardiometabolic disorders. In the context of atherosclerosis, overactivation of conventional calpain attenuates the barrier function of vascular endothelial cells and decreases the immunosuppressive effects attributed to lymphatic endothelial cells. In addition, calpain-6 induces aberrant mRNA splicing in macrophages, conferring atheroprone properties. In terms of diabetes, polymorphisms of the calpain-10 gene can modify insulin secretion and glucose disposal. Moreover, conventional calpain reportedly participates in amino acid production from vascular endothelial cells to induce alteration of amino acid composition in the liver microenvironment, thereby facilitating steatohepatitis. Such multifaceted functionality of calpain underscores its potential as a promising candidate for pharmaceutical targets for the treatment of cardiometabolic diseases. Consequently, the present review highlights the pivotal role of calpains in the complications of cardiometabolic diseases and embarks upon a characterization of calpains as molecular targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Showa University School of Medicine, Tokyo 142-8555, Japan.
ORCID-Profile: Takuro Miyazaki
Förderung
- Japan Society for the Promotion of Science
- Japan Society for the Promotion of Science KAKENHI
Zitieren
APA
Miyazaki, T. (2023). Calpain and Cardiometabolic Diseases. International Journal of Molecular Sciences, 24(23), 16782. https://doi.org/10.3390/ijms242316782
Vancouver
Miyazaki T. Calpain and Cardiometabolic Diseases. International Journal of Molecular Sciences. 2023;24(23):16782. doi:10.3390/ijms242316782
BibTeX
@article{Miyazaki2023,
author = {Miyazaki, Takuro},
title = {Calpain and Cardiometabolic Diseases},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {23},
pages = {16782},
doi = {10.3390/ijms242316782}
}
EUVIMED